Latest & greatest articles for overdiagnosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on overdiagnosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on overdiagnosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for overdiagnosis

1. Quantification of overdiagnosis in randomised trials of cancer screening: an overview and re-analysis of systematic reviews

Quantification of overdiagnosis in randomised trials of cancer screening: an overview and re-analysis of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2019 PROSPERO

2. Overdiagnosis in primary care: framing the problem and finding solutions. Full Text available with Trip Pro

Overdiagnosis in primary care: framing the problem and finding solutions. Overdiagnosis, is defined as the diagnosis of a condition that, if unrecognized, would not cause symptoms or harm a patient during his or her lifetime, and it is increasingly acknowledged as a consequence of screening for cancer and other conditions. Because preventive care is a crucial component of primary care, which is delivered to the broad population, overdiagnosis in primary care is an important problem from (...) a public health perspective and has far reaching implications. The scope of overdiagnosis as a result of services delivered in primary care is unclear, though overdiagnosis of indolent breast, prostate, thyroid, and lung cancers is well described and overdiagnosis of chronic kidney disease, depression, and attention-deficit/hyperactivity disorder is also recognized. However, overdiagnosis is a known consequence of all screening and can be assumed to occur in many more clinical contexts. Overdiagnosis

2018 BMJ

3. Overdiagnosis

Overdiagnosis Top results for overdiagnosis - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for overdiagnosis The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

4. Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening. (Abstract)

Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening. The toll of inadequate health care is well-substantiated, but recognition is mounting that "too much" is also possible. Overdiagnosis represents one harm of too much medicine, but the concept can be confusing: It is often conflated with related harms (such as overtreatment, misclassification, false-positive results, and overdetection) and is difficult to measure because it cannot be directly observed. Because the U.S (...) . Preventive Services Task Force (USPSTF) issues screening recommendations aimed largely at healthy persons, it has a particular interest in understanding harms related to screening, especially but not limited to overdiagnosis. In support of the USPSTF, the authors summarize the knowledge and provide guidance on defining, estimating, and communicating overdiagnosis in cancer screening. To improve consistency, thinking, and reporting about overdiagnosis, they suggest a specific definition. The authors

2018 Annals of Internal Medicine

5. System change to mitigate overdiagnosis and overtreatment: how can we ensure 'just enough medicine'?

System change to mitigate overdiagnosis and overtreatment: how can we ensure 'just enough medicine'? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

6. Overdiagnosis due to screening mammography for women aged 40 years and over [Cochrane protocol]

Overdiagnosis due to screening mammography for women aged 40 years and over [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

7. Overdiagnosis: what it is and what it isn?t Full Text available with Trip Pro

Overdiagnosis: what it is and what it isn?t Overdiagnosis: what it is and what it isn’t | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis: what it is and what it isn’t Article Text Editorial Overdiagnosis: what it is and what it isn’t Free John Brodersen , , Lisa M Schwartz , Carl Heneghan , Jack William O’Sullivan , Jeffrey K Aronson , Steven Woloshin Statistics from Altmetric.com Why then, can one desire too much

2018 Evidence-Based Medicine

8. Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Full Text available with Trip Pro

Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Article Text Letter Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn ’ t ’ Wendy A Rogers 1 , 2 , Yishai Mintzker 3 Statistics from

2018 Evidence-Based Medicine

9. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. Full Text available with Trip Pro

Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. Objective To analyse stage specific incidence of breast cancer in the Netherlands where women have been invited to biennial mammography screening since 1989 (ages 50-69) and 1997 (ages 70-75), and to assess changes in breast cancer mortality and quantified overdiagnosis.Design Population based study.Setting Mammography screening programme, the Netherlands.Participants Dutch women of all (...) ages, 1989 to 2012.Main outcome measures Stage specific age adjusted incidence of breast cancer from 1989 to 2012. The extra numbers of in situ and stage 1 breast tumours associated with screening were estimated by comparing rates in women aged 50-74 with those in age groups not invited to screening. Overdiagnosis was estimated after subtraction of the lead time cancers. Breast cancer mortality reductions and overdiagnosis during 2010-12 were computed without (scenario 1) and with (scenario 2

2017 BMJ

10. Rising Thyroid Cancer Incidence in Southern India: An Epidemic of Overdiagnosis? Full Text available with Trip Pro

Rising Thyroid Cancer Incidence in Southern India: An Epidemic of Overdiagnosis? Thyroid cancer incidence is rising in high-income countries. This increase in disease burden is attributed to the phenomenon of overdiagnosis.We aimed to investigate trends in thyroid cancer rates in India, focusing on the state of Kerala in southern India, which has reported a high incidence of the disease.Population-based study using data from the National Cancer Registry Program.We used data from the Population (...) to overdiagnosis.

2017 Journal of the Endocrine Society

11. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. (Abstract)

Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Effective breast cancer screening should detect early-stage cancer and prevent advanced disease.To assess the association between screening and the size of detected tumors and to estimate overdiagnosis (detection of tumors that would not become clinically relevant).Cohort study.Denmark from 1980 to 2010.Women aged 35 to 84 years.Screening programs offering biennial mammography for women aged 50 to 69 years (...) beginning in different regions at different times.Trends in the incidence of advanced (>20 mm) and nonadvanced (≤20 mm) breast cancer tumors in screened and nonscreened women were measured. Two approaches were used to estimate the amount of overdiagnosis: comparing the incidence of advanced and nonadvanced tumors among women aged 50 to 84 years in screening and nonscreening areas; and comparing the incidence for nonadvanced tumors among women aged 35 to 49, 50 to 69, and 70 to 84 years in screening

2017 Annals of Internal Medicine

12. Methods for estimating the extent of overdiagnosis of non-cancer conditions

Methods for estimating the extent of overdiagnosis of non-cancer conditions Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2017 PROSPERO

13. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. Full Text available with Trip Pro

Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. The goal of screening mammography is to detect small malignant tumors before they grow large enough to cause symptoms. Effective screening should therefore lead to the detection of a greater number of small tumors, followed by fewer large tumors over time.We used data from the Surveillance, Epidemiology, and End Results (SEER) program, 1975 through 2012, to calculate the tumor-size distribution and size-specific

2016 NEJM

14. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. Full Text available with Trip Pro

Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. 27532827 2016 08 23 2016 08 18 1533-4406 375 7 2016 Aug 18 The New England journal of medicine N. Engl. J. Med. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. 614-7 10.1056/NEJMp1604412 Vaccarella Salvatore S From the International Agency for Research on Cancer, Lyon, France (S.V., S.F., F.B., C.P.W., M.P.); and the Cancer Epidemiology Unit, CRO (Centro di Riferimento Oncologico) Aviano

2016 NEJM

15. A systematic review of the interventions aiming at reducing overdiagnosis and the overuse of diagnostic imaging in the emergency department and inpatient settings when a pulmonary embolism is suspected

A systematic review of the interventions aiming at reducing overdiagnosis and the overuse of diagnostic imaging in the emergency department and inpatient settings when a pulmonary embolism is suspected Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files

2016 PROSPERO

16. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. Full Text available with Trip Pro

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. To determine the optimal method for quantifying and monitoring overdiagnosis in cancer screening over time.Systematic review of primary research studies of any design that quantified overdiagnosis from screening for nine types of cancer. We used explicit criteria to critically appraise individual studies and assess strength of the body of evidence for each study design (double blinded review (...) ), and assessed the potential for each study design to accurately quantify and monitor overdiagnosis over time.PubMed and Embase up to 28 February 2014; hand searching of systematic reviews.English language studies of any design that quantified overdiagnosis for any of nine common cancers (prostate, breast, lung, colorectal, melanoma, bladder, renal, thyroid, and uterine); excluded case series, case reports, and reviews that only reported results of other studies.52 studies met the inclusion criteria. We

2015 BMJ

17. Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis

Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Article Text Therapeutics/Prevention Observational study US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Rebecca A Hubbard Statistics from Altmetric.com Commentary on: Harding C , Pompei F , Burmistrov D , et al . Breast Cancer Screening, Incidence

2015 Evidence-Based Medicine

18. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 Cancer Australia

19. Overdiagnosis from mammographic screening

Overdiagnosis from mammographic screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 MHRA Drug Safety Update

20. Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk

Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your (...) browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis in breast cancer screening: women have

2014 Evidence-Based Nursing